CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-10-07 | KOZARICH JOHN W Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,500 | 0 | ||
| 2014-10-01 | Aryeh Jason Director | Exercise or conversion | +7,335 | $32.30 | $237K | 60,695 |
| 2014-10-01 | Aryeh Jason Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,335 | 0 | ||
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion | +630 | $6.82 | $4K | 33,690 |
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion | +7,335 | $12.53 | $92K | 41,025 |
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion | +2,500 | $17.88 | $45K | 43,525 |
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion | +2,500 | $8.58 | $21K | 46,025 |
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion | +7,335 | $10.12 | $74K | 53,360 |
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −630 | 0 | ||
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,500 | 0 | ||
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,335 | 0 | ||
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,335 | 0 | ||
| 2014-09-25 | Aryeh Jason Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,500 | 0 | ||
| 2014-08-15 | HIGGINS JOHN L President & CEO | Purchase | +1,000 | $54.97 | $55K | 120,099 |
| 2014-06-30 | Herman Melanie J Director of Accounting | Purchase | +98 | $43.79 | $4K | 2,728 |
| 2014-06-30 | Berkman Charles S VP, Gen. Counsel & Secretary | Purchase | +329 | $43.79 | $14K | 27,307 |
| 2014-06-30 | FOEHR MATTHEW W EVP and COO | Purchase | +428 | $43.79 | $19K | 53,885 |
| 2014-06-09 | Herman Melanie J Director of Accounting | Exercise or conversion | +850 | $11.91 | $10K | 3,480 |
| 2014-06-09 | Herman Melanie J Director of Accounting | Sale | −850 | $69.68 | $59K | 2,630 |
| 2014-06-09 | Herman Melanie J Director of Accounting | Exercise or conversion | +250 | $14.47 | $4K | 2,880 |
Page 72 of 86 · 1,712 trades